Phibro Animal Health (PAHC) Cash from Operations (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Cash from Operations came in at 16206000.0 in Q1 2026, down 62.45% year-on-year from 43154000.0 in Q1 2025, and down 16.26% quarter-over-quarter from 19352000.0 in Q4 2025.
Phibro Animal Health (PAHC) Cash from Operations (2013 - 2026) Analysis & Trends
Phibro Animal Health's Cash from Operations history runs 14 years deep, the most recent figure standing at 16206000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 62.45% year-over-year to 16206000.0 in Q1 2026; TTM through Mar 2026 was 66132000.0, a 24.23% decrease from a year earlier, with the FY2025 full-year figure at 80124000.0, down 8.53% from the prior year.
- Cash from Operations fell to 16206000.0 in Q1 2026 per PAHC's latest filing, from 19352000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 43154000.0 in Q1 2025 and bottomed at 10698000.0 in Q3 2022.
- The 5-year median for Cash from Operations is 12622000.0 (2024), against an average of 13740823.53.
- Across the five-year window, Cash from Operations sank 379.98% in 2022 and surged 1367.9% in 2023, its largest moves.
- Year by year, Cash from Operations stood at 2489000.0 in 2022, then jumped by 1367.9% to 31558000.0 in 2023, then plunged by 90.25% to 3076000.0 in 2024, then jumped by 529.13% to 19352000.0 in 2025, then fell by 16.26% to 16206000.0 in 2026.
- Per Business Quant, the three latest PAHC Cash from Operations figures stand at 16206000.0 (Q1 2026), 19352000.0 (Q4 2025), and 9302000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 16.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.21 Mn |
| Mar 31, 2026 | 16.21 Mn |
| Dec 31, 2025 | 19.35 Mn |
| Dec 31, 2025 | 19.35 Mn |
| Sep 30, 2025 | 9.30 Mn |
| Sep 30, 2025 | 9.30 Mn |
| Jun 30, 2025 | 21.27 Mn |
| Jun 30, 2025 | 21.27 Mn |
| Mar 31, 2025 | 43.15 Mn |
| Mar 31, 2025 | 43.15 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 12.62 Mn |
| Sep 30, 2024 | 12.62 Mn |
| Jun 30, 2024 | 28.43 Mn |
| Jun 30, 2024 | 28.43 Mn |
| Mar 31, 2024 | 11.41 Mn |
| Mar 31, 2024 | 11.41 Mn |
| Dec 31, 2023 | 31.56 Mn |
| Dec 31, 2023 | 31.56 Mn |